Clinical Trials List
2025-09-01 - 2032-12-31
Phase III
Recruiting6
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- 高理鈞 Division of General Surgery
- Chung-Liang Li Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 郭家瑜 Division of General Surgery
- 巫承哲 Division of General Surgery
- Fang-Ming Chen Division of General Surgery
- 高捷妮 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭懿萱 無
- Chi-Cheng Huang 無
- 鄭涵方 無
- 邱仁輝 無
- 馮晉榮 無
- Yi-Fang Tsai 無
- 林燕淑 無
- Chun-Yu Liu 無
- Jiun-I Lai 無
- 陳彥蓁 無
- Ta-Chung Chao 無
- 賴亦貞 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
1000 participants
